RxDoctor Payments DataLook up a doctor →

David Weir

Family · Dallas, TXNPI 1750876785

Payments from drug & device makers

$958,697in general payments, 2019–2025

Across 699 payments — averaging $1371.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Revance Therapeutics, Inc.$955K
  • Galderma Laboratories, L.p.$1K
  • AbbVie$1K
  • Merz North America, Inc.$812
  • Integra Lifesciences Corporation$167
  • Teva Pharmaceuticals USA, Inc.$121
  • plus $192 from 3 others
$727in research payments, 2019–2025

Across 6 payments — averaging $121.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$727

What the payments were for

  • Consulting fees$1,2380%
  • Speaking & faculty fees$816,85085%
  • Travel & lodging$119,31312%
  • Food & beverage$21,2962%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$958,697 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Other family in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →